DICER1 and pleuropulmonary blastoma: A screening of DICER1 mutations in pediatric DTC as well as thyroid screening ultrasound is recommended for school children with DICER1, which may be followed up every five years or more frequently for those patients under chemotherapy, as children under high-dose chemotherapy for PPB are more prone to develop DTC [11,78,81].